Literature DB >> 19550120

Inhibitory effect of shRNA targeting GPR48 on invasion and metastasis of human cervical carcinoma cell line HeLa.

Yun Gao1, Zhong-Yan Shan, Hong Wang, Hong-Mei Zhang, Wei-Ping Teng.   

Abstract

BACKGROUND AND
OBJECTIVE: GPR48 regulates invasion and metastasis of cancer cells by linking Gs protein to stimulate intracellular signaling pathway and affect actin filament aggregation and the activity of matrix metalloproteinase. This study was to explore the effects of GPR48 short hairpin RNA (shRNA) on GPR48 expression, and invasion and metastasis of cervical carcinoma cell line HeLa.
METHODS: Plasmids containing two different sequences of human GPR48 mRNA coding region were constructed and transfected into HeLa cells. HeLa cell clones with stable small interfering RNA (siRNA) expression were screened by neomycin resistance. The expression of GPR48 was detected by reverse transcription-polymerase chain reaction (RT-PCR) and western blot. In vitro invasive activity was measured by Boyden chamber experiment. GPR48 shRNA-transfected or untransfected HeLa cells were inoculated subcutaneously into nude mice to observe tumor growth and lung metastasis.
RESULTS: Compared with that in negative shRNA-transfected cells, GPR48 mRNA expression in GPR48 shRNA-transfected cells was downregulated by more than 80% and the number of HeLa cells infiltrated Boyden chamber membrane was decreased (94.4 +/- 15.7 vs. 28.3 +/- 1.5 and 17.6 +/- 1.5, p < 0.01). The depletion of endogenous GPR48 suppressed in vivo metastasis: the number of lung metastases was significantly larger in negative shRNA group than in GPR48 shRNA groups (7.3 +/- 1.8 vs. 1.3 +/- 0.3 and 1.5 +/- 0.4, p < 0.01).
CONCLUSION: GPR48 shRNA can inhibit in vitro invasion and in vivo metastasis of HeLa cells efficiently.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19550120

Source DB:  PubMed          Journal:  Ai Zheng


  7 in total

Review 1.  Acute and chronic regulation of aldosterone production.

Authors:  Namita G Hattangady; Lawrence O Olala; Wendy B Bollag; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2011-08-04       Impact factor: 4.102

2.  LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells.

Authors:  Zhiying Yue; Zengjin Yuan; Li Zeng; Ying Wang; Li Lai; Jing Li; Peng Sun; Xiwen Xue; Junyi Qi; Zhengfeng Yang; Yansen Zheng; Yuanzhang Fang; Dali Li; Stefan Siwko; Yi Li; Jian Luo; Mingyao Liu
Journal:  FASEB J       Date:  2017-12-21       Impact factor: 5.191

3.  Lgr4/Gpr48 negatively regulates TLR2/4-associated pattern recognition and innate immunity by targeting CD14 expression.

Authors:  Bing Du; Weijia Luo; Ruimei Li; Binghe Tan; Honghui Han; Xiaoling Lu; Dali Li; Min Qian; Dekai Zhang; Yongxiang Zhao; Mingyao Liu
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

4.  LGR4 and LGR6 are differentially expressed and of putative tumor biological significance in gastric carcinoma.

Authors:  Jan Simon Steffen; Eva Simon; Viktoria Warneke; Katharina Balschun; Matthias Ebert; Christoph Röcken
Journal:  Virchows Arch       Date:  2012-08-02       Impact factor: 4.064

5.  Comprehensive RNA-Seq expression analysis of sensory ganglia with a focus on ion channels and GPCRs in Trigeminal ganglia.

Authors:  Stavros Manteniotis; Ramona Lehmann; Caroline Flegel; Felix Vogel; Adrian Hofreuter; Benjamin S P Schreiner; Janine Altmüller; Christian Becker; Nicole Schöbel; Hanns Hatt; Günter Gisselmann
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

Review 6.  Emerging Roles for LGR4 in Organ Development, Energy Metabolism and Carcinogenesis.

Authors:  Linlin Yang; Jing Wang; Xiaodi Gong; Qiong Fan; Xiaoming Yang; Yunxia Cui; Xiaoyan Gao; Lijuan Li; Xiao Sun; Yuhong Li; Yudong Wang
Journal:  Front Genet       Date:  2022-01-24       Impact factor: 4.599

7.  Comparative expression study of the endo-G protein coupled receptor (GPCR) repertoire in human glioblastoma cancer stem-like cells, U87-MG cells and non malignant cells of neural origin unveils new potential therapeutic targets.

Authors:  Marie Fève; Jean-Michel Saliou; Maria Zeniou; Sarah Lennon; Christine Carapito; Jihu Dong; Alain Van Dorsselaer; Marie-Pierre Junier; Hervé Chneiweiss; Sarah Cianférani; Jacques Haiech; Marie-Claude Kilhoffer
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.